

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * immunoglobulin mediated immune response (GO:0016064) | 6.22006170 |
| 2 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.97836585 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15602211 |
| 4 | regulation of antigen processing and presentation (GO:0002577) | 5.11953012 |
| 5 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.93389161 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.82786461 |
| 7 | * B cell mediated immunity (GO:0019724) | 4.80113309 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 4.68616389 |
| 9 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.40240413 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.32778595 |
| 11 | detection of bacterium (GO:0016045) | 4.32223037 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.28974537 |
| 13 | detection of other organism (GO:0098543) | 4.22785187 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20986104 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12080774 |
| 16 | response to peptidoglycan (GO:0032494) | 4.08141790 |
| 17 | T-helper 1 type immune response (GO:0042088) | 4.00832135 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 4.00349269 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.98375665 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97861281 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.93745410 |
| 22 | cellular response to interferon-gamma (GO:0071346) | 3.88700994 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.81354252 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78629379 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.78629379 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78629379 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78629379 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78629379 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.78629379 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.69409037 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69409037 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.58151996 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.58151996 |
| 34 | defense response to protozoan (GO:0042832) | 3.56895736 |
| 35 | response to type I interferon (GO:0034340) | 3.55968953 |
| 36 | response to interferon-gamma (GO:0034341) | 3.50987319 |
| 37 | positive regulation of type 2 immune response (GO:0002830) | 3.50818260 |
| 38 | T cell costimulation (GO:0031295) | 3.50644874 |
| 39 | lymphocyte costimulation (GO:0031294) | 3.45337995 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41463591 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39366112 |
| 42 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.39034238 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.37751236 |
| 44 | response to protozoan (GO:0001562) | 3.33593211 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32813849 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.28096707 |
| 47 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.25855577 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.23219878 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.21641626 |
| 50 | regulation of mast cell activation (GO:0033003) | 3.19382038 |
| 51 | * positive thymic T cell selection (GO:0045059) | 3.19082824 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.18708107 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.17864140 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17050150 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.10985921 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.09770880 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 3.09338541 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.09338541 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.08215107 |
| 60 | response to interferon-beta (GO:0035456) | 3.03629493 |
| 61 | germinal center formation (GO:0002467) | 3.02907441 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 3.01927216 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.00105704 |
| 64 | production of molecular mediator of immune response (GO:0002440) | 2.99909537 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99573111 |
| 66 | microglial cell activation (GO:0001774) | 2.98919898 |
| 67 | mature B cell differentiation involved in immune response (GO:0002313) | 2.96801127 |
| 68 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94627756 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.94535861 |
| 70 | regulation of B cell apoptotic process (GO:0002902) | 2.90528786 |
| 71 | response to host immune response (GO:0052572) | 2.90323271 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90323271 |
| 73 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87244259 |
| 74 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86181981 |
| 75 | negative T cell selection (GO:0043383) | 2.84877328 |
| 76 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84683988 |
| 77 | regulation of germinal center formation (GO:0002634) | 2.84326269 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83388641 |
| 79 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.82984830 |
| 80 | * adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.80319547 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80201005 |
| 82 | T cell migration (GO:0072678) | 2.77977824 |
| 83 | granulocyte activation (GO:0036230) | 2.77544451 |
| 84 | neutrophil activation (GO:0042119) | 2.77092450 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75902427 |
| 86 | cellular response to exogenous dsRNA (GO:0071360) | 2.75592158 |
| 87 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.75110842 |
| 88 | positive regulation of macrophage cytokine production (GO:0060907) | 2.74126948 |
| 89 | myeloid dendritic cell differentiation (GO:0043011) | 2.73671320 |
| 90 | positive regulation of B cell activation (GO:0050871) | 2.69591962 |
| 91 | macrophage activation (GO:0042116) | 2.69527796 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 2.69351230 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 2.68820383 |
| 94 | negative regulation of innate immune response (GO:0045824) | 2.68701635 |
| 95 | regulation of tolerance induction (GO:0002643) | 2.67484387 |
| 96 | regulation of hypersensitivity (GO:0002883) | 2.66767852 |
| 97 | regulation of interleukin-12 production (GO:0032655) | 2.65221814 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.65058550 |
| 99 | regulation of type 2 immune response (GO:0002828) | 2.64604048 |
| 100 | mast cell activation (GO:0045576) | 2.64152619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.99625850 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.17779843 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68404529 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.12634950 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.51823350 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.26886983 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08648953 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02667922 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94759573 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86872634 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86676113 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51284123 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50945831 |
| 14 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.47756276 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37054989 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.36508937 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33000122 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28906496 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.28488181 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28004778 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27834938 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24107147 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18570627 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17349248 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14744998 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01923451 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98994883 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.96391987 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88343068 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87987694 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.84858904 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81385436 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79534876 |
| 34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.77058520 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76629604 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75438760 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73955575 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71569470 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71017652 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68177003 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67178749 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63726306 |
| 43 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.63123722 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61729793 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58803355 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55852978 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55034930 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44307966 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42704136 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39813052 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34752235 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34142792 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34038465 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.31122643 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27570282 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25443035 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22959462 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22603893 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21303520 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20882848 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18684116 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17228090 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16277335 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15932905 |
| 65 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.14854603 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14458247 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11693036 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11066244 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08852041 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08049144 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07714127 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07569802 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07130058 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06610986 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05751713 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03571442 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03286237 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03071123 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02240752 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99871331 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99344252 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 0.98227792 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96749680 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94791758 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93510577 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91828852 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91592663 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87150946 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87073081 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85219608 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82706758 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81055320 |
| 93 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79863754 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78812260 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78800366 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78373318 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76702737 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76661206 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75909279 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75199351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.68631040 |
| 2 | MP0003303_peritoneal_inflammation | 3.49110585 |
| 3 | MP0005671_abnormal_response_to | 3.46183298 |
| 4 | MP0003436_decreased_susceptibility_to | 3.27354326 |
| 5 | MP0001790_abnormal_immune_system | 3.26685772 |
| 6 | MP0005387_immune_system_phenotype | 3.26685772 |
| 7 | MP0003724_increased_susceptibility_to | 3.22778947 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.21307522 |
| 9 | MP0001800_abnormal_humoral_immune | 3.14749506 |
| 10 | MP0000685_abnormal_immune_system | 3.11338745 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.04039191 |
| 12 | MP0009785_altered_susceptibility_to | 2.90328670 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.77806026 |
| 14 | MP0002419_abnormal_innate_immunity | 2.75432287 |
| 15 | MP0005025_abnormal_response_to | 2.71533197 |
| 16 | MP0002723_abnormal_immune_serum | 2.66916261 |
| 17 | MP0006082_CNS_inflammation | 2.49920035 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.45367232 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.44632865 |
| 20 | MP0001819_abnormal_immune_cell | 2.43055030 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.14211839 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.13001916 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.12535453 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.00877237 |
| 25 | MP0000716_abnormal_immune_system | 1.88693239 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.87620083 |
| 27 | MP0002405_respiratory_system_inflammati | 1.82741707 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.82094938 |
| 29 | MP0002398_abnormal_bone_marrow | 1.81789839 |
| 30 | MP0009840_abnormal_foam_cell | 1.76735727 |
| 31 | MP0009278_abnormal_bone_marrow | 1.75467039 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.73261329 |
| 33 | MP0009764_decreased_sensitivity_to | 1.71768955 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.71192694 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.70573845 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.70257461 |
| 37 | MP0003075_altered_response_to | 1.69386077 |
| 38 | MP0004947_skin_inflammation | 1.67292992 |
| 39 | MP0001853_heart_inflammation | 1.66899603 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.65327016 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.65327016 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.65185762 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.62254237 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.61956187 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.59677759 |
| 46 | MP0008469_abnormal_protein_level | 1.59430172 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.57637220 |
| 48 | MP0002429_abnormal_blood_cell | 1.50738563 |
| 49 | MP0002722_abnormal_immune_system | 1.40147903 |
| 50 | MP0005310_abnormal_salivary_gland | 1.37387968 |
| 51 | MP0000343_altered_response_to | 1.35328784 |
| 52 | MP0001873_stomach_inflammation | 1.30397624 |
| 53 | MP0005166_decreased_susceptibility_to | 1.27937047 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.24951464 |
| 55 | MP0000604_amyloidosis | 1.22579059 |
| 56 | MP0003866_abnormal_defecation | 1.18155227 |
| 57 | MP0005451_abnormal_body_composition | 1.18135632 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.16763213 |
| 59 | MP0002006_tumorigenesis | 1.12532694 |
| 60 | MP0000858_altered_metastatic_potential | 1.08270758 |
| 61 | MP0001663_abnormal_digestive_system | 0.99716793 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 0.92303917 |
| 63 | MP0009763_increased_sensitivity_to | 0.92197964 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.91499300 |
| 65 | MP0003448_altered_tumor_morphology | 0.91207337 |
| 66 | MP0003828_pulmonary_edema | 0.91092269 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.90936152 |
| 68 | MP0008004_abnormal_stomach_pH | 0.90741822 |
| 69 | MP0002132_abnormal_respiratory_system | 0.90401987 |
| 70 | MP0004510_myositis | 0.87666908 |
| 71 | MP0005165_increased_susceptibility_to | 0.83127917 |
| 72 | MP0000249_abnormal_blood_vessel | 0.82996609 |
| 73 | MP0002933_joint_inflammation | 0.81422867 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.80015709 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.78354430 |
| 76 | MP0000490_abnormal_crypts_of | 0.77258560 |
| 77 | MP0003690_abnormal_glial_cell | 0.74239888 |
| 78 | MP0004883_abnormal_blood_vessel | 0.73675982 |
| 79 | MP0005390_skeleton_phenotype | 0.73442806 |
| 80 | MP0008260_abnormal_autophagy | 0.73025820 |
| 81 | MP0005360_urolithiasis | 0.71942575 |
| 82 | MP0001851_eye_inflammation | 0.70548283 |
| 83 | MP0005164_abnormal_response_to | 0.69258955 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.65021762 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.64302021 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.64294708 |
| 87 | MP0005365_abnormal_bile_salt | 0.63489253 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.62467074 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.60043288 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.59626441 |
| 91 | MP0003795_abnormal_bone_structure | 0.58108866 |
| 92 | MP0003045_fibrosis | 0.57955316 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.56457630 |
| 94 | MP0000609_abnormal_liver_physiology | 0.56001678 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55075179 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.54569200 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.53362732 |
| 98 | MP0005535_abnormal_body_temperature | 0.51049177 |
| 99 | MP0001764_abnormal_homeostasis | 0.50889572 |
| 100 | MP0008874_decreased_physiological_sensi | 0.50625076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.82373255 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.67009745 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.67009745 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.67009745 |
| 5 | Meningitis (HP:0001287) | 4.33515861 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.33467219 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.29816931 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 4.17988098 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.10993692 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.10088675 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.05777894 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.04261183 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.87537996 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87391611 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.72338342 |
| 16 | Obstructive lung disease (HP:0006536) | 3.69526575 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.69526575 |
| 18 | Myositis (HP:0100614) | 3.64256275 |
| 19 | Vasculitis (HP:0002633) | 3.62146482 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.53287123 |
| 21 | Abnormality of the prostate (HP:0008775) | 3.52544594 |
| 22 | Pulmonary infiltrates (HP:0002113) | 3.49054448 |
| 23 | Recurrent viral infections (HP:0004429) | 3.46753496 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37366290 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37366290 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25350863 |
| 27 | Orchitis (HP:0100796) | 3.23101749 |
| 28 | Recurrent skin infections (HP:0001581) | 3.21620540 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 3.18882191 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.18868879 |
| 31 | Colitis (HP:0002583) | 3.18854719 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.16728174 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.15259080 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13661081 |
| 35 | Cellulitis (HP:0100658) | 3.12182415 |
| 36 | Optic neuritis (HP:0100653) | 3.11412377 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 3.11412377 |
| 38 | Dysostosis multiplex (HP:0000943) | 3.07027014 |
| 39 | Stomatitis (HP:0010280) | 3.04529321 |
| 40 | Urticaria (HP:0001025) | 3.02048743 |
| 41 | Encephalitis (HP:0002383) | 2.95866237 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.90360671 |
| 43 | Hemoptysis (HP:0002105) | 2.87678972 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.84453245 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.84062232 |
| 46 | Chest pain (HP:0100749) | 2.81015840 |
| 47 | Restrictive lung disease (HP:0002091) | 2.71213253 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.69323284 |
| 49 | B lymphocytopenia (HP:0010976) | 2.68179598 |
| 50 | Increased IgM level (HP:0003496) | 2.60059274 |
| 51 | Abnormality of the pleura (HP:0002103) | 2.57329131 |
| 52 | Petechiae (HP:0000967) | 2.56258212 |
| 53 | Loss of speech (HP:0002371) | 2.55967960 |
| 54 | Osteomyelitis (HP:0002754) | 2.55559583 |
| 55 | Purpura (HP:0000979) | 2.51514646 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.51101066 |
| 57 | Abnormality of T cells (HP:0002843) | 2.49595384 |
| 58 | Pustule (HP:0200039) | 2.47019235 |
| 59 | Pulmonary fibrosis (HP:0002206) | 2.46273855 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.46242548 |
| 61 | Chronic diarrhea (HP:0002028) | 2.43654738 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.43444982 |
| 63 | Granulocytopenia (HP:0001913) | 2.42719992 |
| 64 | Increased IgE level (HP:0003212) | 2.42710107 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.41574679 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.39469641 |
| 67 | Skin rash (HP:0000988) | 2.37343688 |
| 68 | T lymphocytopenia (HP:0005403) | 2.36606106 |
| 69 | Epistaxis (HP:0000421) | 2.36428698 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.34823808 |
| 71 | Lymphopenia (HP:0001888) | 2.33792078 |
| 72 | Chronic otitis media (HP:0000389) | 2.33765340 |
| 73 | Pulmonary embolism (HP:0002204) | 2.32188544 |
| 74 | Eosinophilia (HP:0001880) | 2.31948728 |
| 75 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31699696 |
| 76 | Glomerulonephritis (HP:0000099) | 2.31579471 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31222656 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31222656 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31222656 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.29958659 |
| 81 | Gangrene (HP:0100758) | 2.28126609 |
| 82 | IgM deficiency (HP:0002850) | 2.27146283 |
| 83 | Prostate neoplasm (HP:0100787) | 2.26955526 |
| 84 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26066107 |
| 85 | Leukocytosis (HP:0001974) | 2.25175592 |
| 86 | IgG deficiency (HP:0004315) | 2.24469664 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.23970237 |
| 88 | Verrucae (HP:0200043) | 2.22847516 |
| 89 | Papilloma (HP:0012740) | 2.22847516 |
| 90 | Increased serum ferritin (HP:0003281) | 2.21900726 |
| 91 | Disinhibition (HP:0000734) | 2.19941327 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.15279165 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.12643145 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12643145 |
| 95 | Arterial thrombosis (HP:0004420) | 2.12083388 |
| 96 | Gingivitis (HP:0000230) | 2.11799176 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.11195658 |
| 98 | Sepsis (HP:0100806) | 2.11038541 |
| 99 | Hypertensive crisis (HP:0100735) | 2.08758869 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.08323621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.34640402 |
| 2 | RIPK4 | 4.14210974 |
| 3 | BLK | 3.29145282 |
| 4 | ERN1 | 3.01805622 |
| 5 | KIT | 2.75680674 |
| 6 | TYK2 | 2.59214590 |
| 7 | CSF1R | 2.54914029 |
| 8 | TBK1 | 2.54269925 |
| 9 | MAP3K14 | 2.47973672 |
| 10 | BMPR2 | 2.44177170 |
| 11 | SYK | 2.42151654 |
| 12 | FES | 2.27016926 |
| 13 | IRAK4 | 2.11884766 |
| 14 | TAOK3 | 2.11176391 |
| 15 | IKBKB | 2.04278555 |
| 16 | IKBKE | 2.01927053 |
| 17 | TXK | 2.00095405 |
| 18 | BTK | 1.99423852 |
| 19 | NME2 | 1.99232899 |
| 20 | JAK3 | 1.94900062 |
| 21 | CSK | 1.75204477 |
| 22 | LYN | 1.73815243 |
| 23 | MAP3K13 | 1.69887885 |
| 24 | TEC | 1.68335660 |
| 25 | ZAP70 | 1.55428551 |
| 26 | ITK | 1.52018214 |
| 27 | GRK7 | 1.48935519 |
| 28 | TESK2 | 1.46841732 |
| 29 | MATK | 1.45936423 |
| 30 | MAP2K3 | 1.43103269 |
| 31 | HCK | 1.35286179 |
| 32 | PRPF4B | 1.29894354 |
| 33 | TNK2 | 1.28011726 |
| 34 | LCK | 1.23255009 |
| 35 | MAP3K11 | 1.21589489 |
| 36 | IRAK3 | 1.20570716 |
| 37 | MAP3K3 | 1.15888949 |
| 38 | JAK1 | 1.14665953 |
| 39 | TGFBR2 | 1.14194991 |
| 40 | TLK1 | 1.10612132 |
| 41 | GRK6 | 1.07216223 |
| 42 | SIK3 | 1.05703355 |
| 43 | FGR | 1.04577046 |
| 44 | BCKDK | 1.01462495 |
| 45 | ADRBK2 | 0.95199197 |
| 46 | KDR | 0.94316112 |
| 47 | JAK2 | 0.93006557 |
| 48 | PRKCQ | 0.82032136 |
| 49 | CDC42BPA | 0.79949621 |
| 50 | CDK19 | 0.79499328 |
| 51 | MAP3K10 | 0.77195813 |
| 52 | CHUK | 0.74250202 |
| 53 | TAOK2 | 0.73528792 |
| 54 | PDK1 | 0.71924328 |
| 55 | HIPK2 | 0.70572073 |
| 56 | STK10 | 0.68957611 |
| 57 | PIM2 | 0.65553629 |
| 58 | IRAK1 | 0.65458994 |
| 59 | MAPK7 | 0.63959152 |
| 60 | ABL1 | 0.61384844 |
| 61 | PIM1 | 0.61370166 |
| 62 | MAP3K1 | 0.60082303 |
| 63 | TRPM7 | 0.59841173 |
| 64 | SMG1 | 0.59579847 |
| 65 | DAPK2 | 0.59415141 |
| 66 | MARK3 | 0.59093111 |
| 67 | TGFBR1 | 0.58463556 |
| 68 | PIK3CG | 0.56114261 |
| 69 | MAPK11 | 0.55043214 |
| 70 | EIF2AK3 | 0.52953600 |
| 71 | TAOK1 | 0.51920965 |
| 72 | MST4 | 0.50392780 |
| 73 | MAPK12 | 0.50254653 |
| 74 | PDPK1 | 0.49203599 |
| 75 | SIK2 | 0.48602958 |
| 76 | LRRK2 | 0.46403347 |
| 77 | VRK2 | 0.46255082 |
| 78 | ACVR1B | 0.44709834 |
| 79 | MAP2K2 | 0.43271942 |
| 80 | MAPKAPK3 | 0.43098494 |
| 81 | FYN | 0.42119941 |
| 82 | RPS6KL1 | 0.42020540 |
| 83 | RPS6KC1 | 0.42020540 |
| 84 | ABL2 | 0.41450521 |
| 85 | BMPR1B | 0.40642938 |
| 86 | MAP3K5 | 0.40253740 |
| 87 | DAPK1 | 0.39909075 |
| 88 | PRKCD | 0.38747102 |
| 89 | RPS6KA6 | 0.38595878 |
| 90 | MOS | 0.38538074 |
| 91 | MAP2K6 | 0.37687663 |
| 92 | MAPKAPK2 | 0.36710302 |
| 93 | MAPK4 | 0.36658251 |
| 94 | IGF1R | 0.36471447 |
| 95 | IRAK2 | 0.34975273 |
| 96 | CDK4 | 0.34930604 |
| 97 | CDK6 | 0.33675907 |
| 98 | FLT3 | 0.32361886 |
| 99 | DAPK3 | 0.30496136 |
| 100 | CDK9 | 0.30118171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 5.10335444 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.78390948 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.43018675 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.38178815 |
| 5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.19280758 |
| 6 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.68463280 |
| 7 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.65842204 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.05362843 |
| 9 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.94952516 |
| 10 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.82382854 |
| 11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.57042716 |
| 12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.39470800 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39199686 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01195420 |
| 15 | * Tuberculosis_Homo sapiens_hsa05152 | 1.89365480 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87786115 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69954793 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67069728 |
| 19 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.65899221 |
| 20 | * Influenza A_Homo sapiens_hsa05164 | 1.51348885 |
| 21 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.49192760 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46951811 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39931098 |
| 24 | * Phagosome_Homo sapiens_hsa04145 | 1.35095334 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.33006976 |
| 26 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.28341801 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.16100265 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11074829 |
| 29 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10114080 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09878744 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00086999 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94395654 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93965498 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 0.90192660 |
| 35 | Measles_Homo sapiens_hsa05162 | 0.89321451 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.89232588 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80153184 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78048250 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77192633 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73924730 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69518794 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69494387 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69281220 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69074015 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68636886 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65785784 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61544019 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.60260305 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55298761 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.52765151 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.50688728 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.49891714 |
| 53 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.49538107 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47224859 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44080861 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43697319 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.43457189 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.42467353 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39053707 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33684087 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27844435 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27436316 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27293595 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25400902 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24550662 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22165457 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21816685 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21506644 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20833765 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18150006 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17367507 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15808916 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15542213 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14841985 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13380098 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12384222 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11629456 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11234783 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.11090156 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09631465 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.07342006 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06121329 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05788026 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.05592669 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.05436999 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.05372680 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.05008029 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.04112390 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03763800 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.03761170 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.03253176 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.02298478 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.00328615 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | -0.0402425 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0347546 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0295366 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0217260 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0215933 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | -0.0197418 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0162041 |

